Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Gains from Investment Securities (2017)

Updated

Niki BioSolutions (NIKI) posted Gains from Investment Securities of $9,266 for FY2023, down 93.1% from $134,134 in FY2022.

Analysis

Niki BioSolutions (NIKI) Gains from Investment Securities (2017) Analysis & Trends

Since FY2017, Niki BioSolutions has reported Gains from Investment Securities for 7 years.

  • Annual Gains from Investment Securities has run from a low of $4,289 in FY2021 to a high of $199,031 in FY2020 over five years.
  • Business Quant data shows NIKI's Gains from Investment Securities at $134,134 in FY2022, $4,289 in FY2021 (-97.8%), $199,031 in FY2020 (+143.2%) and $81,839 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Niki BioSolutions 2.51 Mn 2.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -3.91 Mn
API Access

Niki BioSolutions Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=NIKI&period=max&api_key=YOUR_API_KEY